Both target multiple metabolic pathways simultaneously
60-Day money back guarantee* Our site and third parties use cookies and pixels to improve your user experience
BPC-157 (15 amino acids) operates at the signaling/transcriptional level through NO/VEGF pathways, FAK-paxillin activation, and angiogenesis promotionderived from gastric juice with extreme pH stability
Ready to experience the energy-boosting benefits of B12 injections

Red Flags in Before and After Photos Different lighting: Bathroom fluorescent light vs golden-hour window light can make anyone's skin look dramatically different regardless of what product was used Different camera distance or angle: Even a few inches closer creates apparent texture smoothing "Results in 1 week": Anyone showing dramatic wrinkle reversal in one week is using either injectable delivery, a film-forming agent for temporary tightening, or misleading photography No defined timeframe: Legitimate results specify exactly how many weeks of use are shown No single variable: If the person changed multiple products during the documented period, you cannot attribute results to GHK-Cu specifically Green Flags in Credible Documentation Identical lighting in both photos (same room, same time of day, same source) 3D imaging or VISIA documentation the gold standard used in clinical studies Specified timeline with consistent single-product use Progressive documentation (4-week, 8-week, 12-week) rather than a single dramatic comparison Honest acknowledgment that results vary and are gradual The clinical studies that produced GHK-Cu's most impressive numbers 55.8% wrinkle volume reduction used VISIA 3D profilometry imaging systems that eliminate all lighting and angle variables entirely

Key effects associated with BPC-157: Tendon and ligament repair support Muscle injury recovery Gut lining protection Inflammation modulation Improved tissue perfusion Possible neuroprotective effects Importantly, much of the BPC-157 literature is preclinical meaning it comes from animal or laboratory studies rather than large human clinical trials